Disc Medicine, Inc.
bitopertin
erythropoietic protoporphyria (EPP)
Countdown
177days
Approval decision · ~ Dec 31, 2026 estimated
What's at stake
A final FDA approval decision on bitopertin for erythropoietic protoporphyria (EPP) is expected ~ Dec 31, 2026.
Primary source
· SEC 8-K
verified 14h ago
“Potential FDA approval and launch APOLLO topline – late 2026 / early 2027”